Loxo Oncology CS (LOXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | LOXO | JAZZ | GRFS | ||
Company | Loxo Oncology CS | Jazz Pharma Plc | Grifols S.A. ADR | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 234.80 | 114.50 | 8.54 | ||
High | 234.80 | 115.43 | 8.67 | ||
Low | 234.80 | 113.83 | 8.44 | ||
Last | 234.80 | 115.04 | 8.65 | ||
Change | +0.14 | +0.41 | +0.06 | ||
% Change | +0.06% | +0.36% | +0.70% | ||
Volume | 800 | 391,100 | 410,300 | ||
20-Day Average Volume | 642,620 | 556,135 | 604,745 | ||
Previous Close | 234.66 | 114.63 | 8.59 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 234.28 | 110.44 | 8.73 | ||
20-Day Raw Stochastic | 92.26% | 70.87% | 76.77% | ||
20-Day Relative Strength | 75.87% | 58.08% | 51.03% | ||
Weighted Alpha | +47.60 | -9.37 | +36.42 | ||
Today's Opinion | 100% Buy | 40% Buy | 80% Buy | ||
Previous Opinion | 100% Buy | 40% Buy | 80% Buy | ||
Last Month's Opinion | 56% Buy | 8% Sell | 88% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +0.16% since 02/08/19 | +5.74% since 10/11/24 | +0.70% since 10/11/24 | ||
Low | 234.43 on 02/11/19 | 108.93 on 10/14/24 | 8.41 on 10/14/24 | ||
High | 234.93 on 02/13/19 | 118.67 on 10/16/24 | 8.76 on 10/14/24 | ||
1-Month | |||||
%Chg | +0.48% since 01/15/19 | +5.00% since 09/18/24 | -1.03% since 09/18/24 | ||
Low | 233.14 on 01/16/19 | 106.21 on 10/10/24 | 7.13 on 09/25/24 | ||
High | 234.93 on 02/13/19 | 118.67 on 10/16/24 | 9.16 on 09/19/24 | ||
3-Month | |||||
%Chg | +54.95% since 11/15/18 | +5.70% since 07/18/24 | +6.53% since 07/18/24 | ||
Low | 125.00 on 12/24/18 | 104.42 on 09/11/24 | 6.70 on 08/13/24 | ||
High | 234.93 on 02/13/19 | 118.67 on 10/16/24 | 9.57 on 08/29/24 | ||
6-Month | |||||
%Chg | +49.33% since 08/15/18 | +5.28% since 04/18/24 | +32.26% since 04/18/24 | ||
Low | 125.00 on 12/24/18 | 99.06 on 07/10/24 | 5.79 on 06/27/24 | ||
High | 234.93 on 02/13/19 | 118.67 on 10/16/24 | 9.57 on 08/29/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 7,182,943 | 7,254,653 | 5,947,394 | ||
Shares Outstanding, K | 30,615 | 63,062 | 687,560 | ||
Annual Sales | 21,300,000 | 3,834,200,000 | 7,134,500,000 | ||
Annual Net Income | -148,880,000 | 414,830,000 | 64,200,000 | ||
Last Quarter Sales | 42,470,000 | 1,023,830,000 | 1,957,700,000 | ||
Last Quarter Net Income | -27,060,000 | 168,570,000 | 15,980,000 | ||
60-Month Beta | 2.51 | 0.57 | 0.50 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.89 on 11/08/18 | 5.30 on 07/31/24 | 0.02 on 07/30/24 | ||
Latest Earnings Date | 03/07/19 | 11/13/24 | 08/01/24 | ||
Most Recent Dividend | N/A | N/A | 0.370 on 06/03/21 | ||
Next Ex-Dividends Date | N/A | N/A | 06/03/21 | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 7.51 | 0.00 |